Cargando…
Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019
A 42-year-old man exhibiting hypoxia was diagnosed with coronavirus disease 2019. He had medical histories of type 2 diabetes, hyperlipidemia, hyperuricemia, and gout attack. He received favipiravir for compassionate use for 14 days. Subsequently, he showed increased uric acid levels and developed a...
Autores principales: | Hase, Ryota, Kurata, Rika, Ishida, Keiko, Kurita, Takashi, Muranaka, Emiri, Mito, Haruki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578611/ https://www.ncbi.nlm.nih.gov/pubmed/32727996 http://dx.doi.org/10.2169/internalmedicine.5377-20 |
Ejemplares similares
-
A Favipiravir-induced Fever in a Patient with COVID-19
por: Kurita, Takashi, et al.
Publicado: (2020) -
A pitfall of cognitive bias during the pandemic: Two cases of Plasmodium falciparum malaria coinfected or misdiagnosed with COVID-19
por: Mito, Haruki, et al.
Publicado: (2023) -
Enterobiasis in the hospitalized patient
por: Muranaka, Emiri, et al.
Publicado: (2023) -
Favipiravir: Hyperuricaemia and acute gouty arthritis following off-label use: case report
Publicado: (2020) -
Potential for false-positive results with quantitative antigen tests for SARS-CoV-2: A case of a child with acute respiratory infection
por: Hase, Ryota, et al.
Publicado: (2022)